The purpose of this Discussion Paper is to obtain feedback from practitioners in the fill and finish operations and device assembly operations of parenteral drug products. The authoring team is seeking input on the potential issues and challenges associated with implementing uniquely identified primary containers for parenteral products within manufacturing operations. In addition, the team is seeking feedback on the proposed technologies and solutions described in this document as well as any additional use cases.